International Journal of Clinical Pharmacy

, Volume 39, Issue 4, pp 743–749 | Cite as

Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina

  • Gordana Ljubojević
  • Branislava Miljković
  • Tatjana Bućma
  • Milica Ćulafić
  • Milica Prostran
  • Sandra Vezmar KovačevićEmail author
Research Article


Background In the last 30 years, activities of hospital pharmacists have gone through significant changes. Pharmacists are increasingly involved in patient care. Objectives To explore drug-related and logistic problems, interventions, and their outcomes during routine everyday work of hospital pharmacists. Setting Institute for physical medicine and rehabilitation, Banja Luka, Bosnia and Herzegovina. Methods In the period of January 2013–October 2015 a prospective observational study was performed. Medical doctors, nurses, therapists, and patients addressed pharmacists, face-to-face or by telephone, with drug-related problems (DRPs) and/or logistic issues. Main outcome measure Type of DRP or logistic issue, intervention, outcome, initiator and time spent for solving the problem were documented for each consultation. Results Out of 1515 interventions, 48.8% were aimed at solving DRPs. The most common DRPs were the recommendation of a drug or dose and need for additional information about drugs. Drug price and supply were the most prevalent logistic issues. DRPs were more frequently initiated by medical doctors and required more time to solve the problem compared to logistic issues (Mann–Whitney U test, p ≤ 0.001, respectively). The acceptance rate of interventions to solve DRPs (83.7%) was lower compared to logistic issues (95.2%; p ≤ 0.001). Conclusions Hospital pharmacists were faced with an approximately equal number of DRPs and logistic issues during their routine everyday work. The overall acceptance rate of pharmacists’ interventions was high, and the results of our study indicate that there is a need for more involvement of hospital pharmacists in Bosnia and Herzegovina in clinical activities. Impact on practice.


Bosnia and Herzegovina Drug-related problems Hospital pharmacists Interventions Logistic issues Outcomes 



This work was conducted as a part of the project No. 175023 funded by the Ministry of Education, Science and Technological Development, Belgrade, Republic of Serbia.

Conflicts of interest

The authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.


  1. 1.
    Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102:275–80.CrossRefPubMedGoogle Scholar
  2. 2.
    Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013;19:408–16.PubMedGoogle Scholar
  3. 3.
    Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Task force on economic evaluation of clinical pharmacy services of the american college of clinical p. evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23:113–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Frontini R, Miharija-Gala T, Sykora J. EAHP, survey 2010 on hospital pharmacy in Europe: part 1. General frame and staffing. Eur J Hosp Pharm. 2012;19:385–7.CrossRefGoogle Scholar
  5. 5.
    Langebrake C, Hilgarth H. Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci. 2010;32:194–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36:1031–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Acheampong F, Anto BP. Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview. BMC Health Serv Res. 2015;15:361.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose FX, et al. Trends in pharmacists’ medication order review in French hospitals from 2006 to 2009: analysis of pharmacists’ interventions from the Act-IP (c) website observatory. J Clin Pharm Ther. 2015;40:32–40.CrossRefPubMedGoogle Scholar
  9. 9.
    O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Cullinan S, O’Sullivan R, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31:471–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Mekonnen AB, Yesuf EA, Odegard PS, Wega SS. Implementing ward based clinical pharmacy services in an Ethiopian university hospital. Pharm Pract. 2013;11:51–7.CrossRefGoogle Scholar
  11. 11.
    Li X, Huo H, Kong W, Li F, Wang J. Physicians’ perceptions and attitudes toward clinical pharmacy services in urban general hospitals in China. Int J Clin Pharm. 2014;36:443–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Sabry N, Farid SF. The role of clinical pharmacists as perceived by Egyptian physicians. Int J Pharm Pract. 2014;22:354–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Awad A, Matowe L, Capps P. Medical doctors’ perceptions and expectations of the role of hospital pharmacists in Sudan. Pharm World Sci. 2007;29:557–64.CrossRefPubMedGoogle Scholar
  14. 14.
    Willoch K, Blix HS, Pedersen-Bjergaard AM, Eek AK, Reikvam A. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm. 2012;34:382–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Aburuz SM, Bulatova NR, Yousef AM, Al-Ghazawi MA, Alawwa IA, Al-Saleh A. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm. 2011;33:501–11.CrossRefPubMedGoogle Scholar
  16. 16.
    Khalili H, Farsaei S, Rezaee H, Dashti-Khavidaki S. Role of clinical pharmacists’ interventions in detection and prevention of medication errors in a medical ward. Int J Clin Pharm. 2011;33:281–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, et al. Analysis of drug-related problems in three departments of a German university hospital. Int J Clin Pharm. 2016;38:119–26.CrossRefPubMedGoogle Scholar
  18. 18.
    Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38:942–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Bourne RS, Choo CL, Dorward BJ. Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors. Int J Pharm Pract. 2014;22:146–54.CrossRefPubMedGoogle Scholar
  20. 20.
    Geller AI, Nopkhun W, Dows-Martinez MN, Strasser DC. Polypharmacy and the role of physical medicine and rehabilitation. PM R. 2012;4:198–219.CrossRefPubMedGoogle Scholar
  21. 21.
    Freeman CR, Cottrell WN, Kyle G, Williams ID, Nissen L. An evaluation of medication review reports across different settings. Int J Clin Pharm. 2013;35:5–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Bergkvist Christensen A, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, et al. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33:1010–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28:152–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:735–47.CrossRefPubMedGoogle Scholar
  25. 25.
    Kaur S, Roberts JA, Roberts MS. Evaluation of medication-related problems in medication reviews: a comparative perspective. Ann Pharmacother. 2012;46:972–82.CrossRefPubMedGoogle Scholar
  26. 26.
    Kwint HF, Faber A, Gussekloo J, Bouvy ML. Completeness of medication reviews provided by community pharmacists. J Clin Pharm Ther. 2014;39:248–52.CrossRefPubMedGoogle Scholar
  27. 27.
    Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012;37:674–80.CrossRefPubMedGoogle Scholar
  28. 28.
    Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001;21:129–41.CrossRefPubMedGoogle Scholar
  29. 29.
    Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy. 2001;21:1023–36.CrossRefPubMedGoogle Scholar
  30. 30.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals. Pharmacotherapy. 1999;19:1354–62.CrossRefPubMedGoogle Scholar
  31. 31.
    Langebrake C, Ihbe-Heffinger A, Leichenberg K, Kaden S, Kunkel M, Lueb M, et al. Nationwide evaluation of day-to-day clinical pharmacists’ interventions in German hospitals. Pharmacotherapy. 2015;35:370–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Klopfer JD, Einarson TR. Acceptance of pharmacists’ suggestions by prescribers: a literature review. Hosp Pharm. 1990;25(830–832):834–6.Google Scholar
  33. 33.
    Zhai XB, Gu ZC, Liu XY. Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis. Ther Clin Risk Manag. 2016;12:241–50.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Jiang SP, Chen J, Zhang XG, Lu XY, Zhao QW. Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Ther Clin Risk Manag. 2014;10:861–6.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Khdour MR, Alayasa KS, Alshahed QN, Hawwa AF. Physicians’ perceptions, attitudes and expectations regarding the role of hospital-based pharmacists in the West Bank, Palestine. Int J Pharm Pract. 2013;21:178–84.CrossRefPubMedGoogle Scholar
  36. 36.
    Tahaineh LM, Wazaify M, Albsoul-Younes A, Khader Y, Zaidan M. Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist. Res Soc Adm Pharm. 2009;5:63–70.CrossRefGoogle Scholar
  37. 37.
    Fahmy SA, Rasool BK, Abdu S. Health-care professionals’ perceptions and expectations of pharmacists’ role in the emergency department, United Arab emirates. East Mediterr Health J. 2013;19:794–801.PubMedGoogle Scholar

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  1. 1.Institute for Physical Medicine and RehabilitationBanja LukaBosnia and Herzegovina
  2. 2.Department of Pharmacokinetics and Clinical Pharmacy, Faculty of PharmacyUniversity of BelgradeBelgradeSerbia
  3. 3.Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of MedicineUniversity of BelgradeBelgradeSerbia

Personalised recommendations